Is iBio Inc. (IBIO) Good For Your Portfolio?

iBio Inc. (AMEX:IBIO) saw a downside of -0.83% to $0.94 after subtracting $0.0 on Wednesday. The 5-day average trading volume is 1,645,854 shares of the company’s common stock. It has gained $0.9899 in the past week. An average of 2,663,649 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,734,634.

IBIO’s 1-month performance is -18.72% or -$0.2252 on its low of $0.9005 reached on 10/07/21. The company’s shares have touched a 52-week low of $0.90 and high of $2.83, with the stock’s rally to the 52-week high happening on 02/10/21. YTD, IBIO has lost -10.20% or -$0.1152. However, the current price is down -66.96%% from the 52-week high price.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Valuation Metrics

iBio Inc. (IBIO) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.20 for the sector.IBIO stock has a beta of -6.06. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 84.36 while the price-to-book (PB) in the most recent quarter is 1.89.

iBio Inc.’s quick ratio for the period ended March 30 was 15.70, with the current ratio over the same period at 15.70 meaning that IBIO stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending March 30 was 0.29, while the total debt to equity was 0.30. In terms of profitability, the gross margin trailing 12 months is 71.30%. The trailing 12-month EBITDA margin is -1210.33%. The firm’s gross profit as reported stood at $0.91 million against revenue of $2.37 million.

Earnings Surprise

For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected IBIO to announce -$0.05 per share in earnings in its latest quarter, but it posted -$0.04, representing a 20.00% surprise. EBITDA for the quarter stood at more than -$8.72 million. IBIO stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 38.4 million, with total debt at $32.72 million. Shareholders hold equity totaling $217.87 million

Technical Picture

Let’s look briefly at iBio Inc. (IBIO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 27.63% to suggest the stock is trending oversold, with historical volatility in this time period at 46.29%.

The stock’s 5-day moving average is $0.9419, reflecting a +1.61% or $0.0148 change from its current price. IBIO is currently trading -16.54% above its 20-day SMA, -36.41% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -24.00% and -16.54% respectively.

Stochastic %K and %D was 12.67% and 14.48% and the average true range (ATR) pointed at 0.0536. The RSI (14) points at 29.71%, while the 14-day stochastic is at 12.27% with the period’s ATR at 0.0563. The stock’s 9-day MACD Oscillator is pointing at -0.0253 and -0.0785 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for iBio Inc. (AMEX: IBIO), Cantor Fitzgerald launched coverage with an Overweight rating. Analysts offering their rating for IBIO stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate IBIO as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.

What is IBIO’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $3.00 and a high of $3.00, with their median price target at $3.00. Looking at these predictions, the average price target given by analysts is for iBio Inc. (IBIO) stock is $3.00.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam